NEONC TECHNOLOGIES HOLDINGS, INC. Proceeds from Related Party Debt
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Proceeds from Related Party Debt of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for the quarter ending 2025-12-31 was $0.00.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for the quarter ending 2025-09-30 was $0.00.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for the quarter ending 2025-03-31 was $300.00K, a 55.29% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for fiscal 2025 was $300.00K, a 66.37% decline from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from related party debt for fiscal 2024 was $892.03K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $300.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $300.00K 10-Q · filed 2025-11-14 | $300.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $300.00K 10-Q · filed 2026-08-10 | $300.00K derived: sum of 3 quarters · filed 2026-08-10 | $300.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-15 | $300.00K derived: sum of 2 quarters · filed 2026-05-15 | $300.00K derived: sum of 3 quarters · filed 2026-05-15 | $521.07K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $221.07K derived: sum of 3 quarters · filed 2026-03-31 | $892.03K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $221.07K derived: sum of 2 quarters · filed 2025-11-14 | $892.03K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $221.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $892.03K 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $670.95K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |